Patents by Inventor James D. Wakefield

James D. Wakefield has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Treatment of metabolic syndrome with an sGC stimulator
    Patent number: 11389449
    Abstract: The present invention provides a method of treating a subject with metabolic syndrome by administering a stimulator of soluble guanylate cyclase (sGC) (Compound I) either alone or in combination therapy with a blood glucose lowering (antihyperglycemic or antidiabetes) medication, a blood pressure lowering (anti-hypertensive) medication, an anti-hyperlipidemic medication, or combinations thereof.
    Type: Grant
    Filed: September 14, 2018
    Date of Patent: July 19, 2022
    Assignee: Cyclerion Therapeutics, Inc.
    Inventors: John P. Hanrahan, Albert Thomas Profy, James D. Wakefield
  • TREATMENT OF METABOLIC SYNDROME WITH AN SGC STIMULATOR
    Publication number: 20200276195
    Abstract: The present invention provides a method of treating a subject with metabolic syndrome by administering a stimulator of soluble guanylate cyclase (sGC) (Compound I) either alone or in combination therapy with a blood glucose lowering (antihyperglycemic or antidiabetes) medication, a blood pressure lowering (anti-hypertensive) medication, an anti-hyperlipidemic medication, or combinations thereof.
    Type: Application
    Filed: September 14, 2018
    Publication date: September 3, 2020
    Inventors: John P. Hanrahan, Albert Thomas Profy, James D. Wakefield